NASDAQ: PHHPark Ha Biological Technology Co Ltd Stock
$33.90+0.28 (+0.83%)
Updated Jun 27, 2025
PHH Price
$33.90
Fair Value Price
$2.92
Market Cap
$888.18M
52 Week Low
$3.70
52 Week High
$34.02
P/E
1,695x
P/B
589.73x
P/S
N/A
PEG
56.13x
Dividend Yield
N/A
Revenue
$2.38M
Earnings
$478.56k
Gross Margin
91.8%
Operating Margin
33.31%
Profit Margin
20.1%
Debt to Equity
1.05
Operating Cash Flow
$960k
Beta
-0.56
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PHH Overview
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PHH's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Household & Personal Product
Industry Rating
C
PHH
Ranked#14 of 28
Ranked#14 of 28
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.09 | A | |
| $5.77 | B | |
| $49.41 | B |
Be the first to know about important PHH news, forecast changes, insider trades & much more!
PHH News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PHH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PHH ($33.90) is overvalued by 1,062.5% relative to our estimate of its Fair Value price of $2.92 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PHH ($33.90) is not significantly undervalued (1,062.5%) relative to our estimate of its Fair Value price of $2.92 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PHH ($33.90) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PHH due diligence checks available for Premium users.
Valuation
PHH fair value
Fair Value of PHH stock based on Discounted Cash Flow (DCF)
Price
$33.90
Fair Value
$2.92
Overvalued by
1,062.50%
PHH ($33.90) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PHH ($33.90) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PHH ($33.90) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PHH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
1,695x
Industry
25.49x
Market
32.24x
PHH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PHH is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PHH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
589.73x
Industry
7.17x
PHH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PHH price to earnings growth (PEG)
For valuing profitable companies with growth potential
PHH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
PHH's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
PHH's Earnings (EBIT) of $793.42k... subscribe to Premium to read more.
Interest Coverage Financials
PHH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.1M
Liabilities
$1.6M
Debt to equity
1.05
PHH's short-term assets ($2.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PHH's short-term assets ($2.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PHH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PHH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
PHH's operating cash flow ($960.47k)... subscribe to Premium to read more.
Debt Coverage Financials
PHH vs Household & Personal Product Stocks
Park Ha Biological Technology Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.